Cim LLC Has $3.33 Million Stake in Doximity, Inc. $DOCS

Key Points

• Cim LLC reduced its holdings in Doximity, Inc. by 18.4%, now owning 57,299 shares worth approximately $3.33 million.
• Doximity reported earnings of $0.36 EPS for the last quarter, exceeding analysts' estimates of $0.31, with a revenue increase of 15.2% year-over-year.
• Various research firms have set new target prices for Doximity, with Goldman Sachs at $50.00 and Robert W. Baird at $80.00, reflecting a range of ratings from "Buy" to "Neutral."

Cim LLC decreased its position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 18.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 57,299 shares of the company's stock after selling 12,943 shares during the quarter. Cim LLC's holdings in Doximity were worth $3,325,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently modified their holdings of DOCS. Cetera Investment Advisers boosted its holdings in shares of Doximity by 14.6% during the fourth quarter. Cetera Investment Advisers now owns 8,097 shares of the company's stock valued at $432,000 after acquiring an additional 1,034 shares during the period. Nuveen Asset Management LLC boosted its holdings in shares of Doximity by 48.0% during the fourth quarter. Nuveen Asset Management LLC now owns 464,658 shares of the company's stock valued at $24,808,000 after acquiring an additional 150,734 shares during the period. Nomura Holdings Inc. acquired a new position in shares of Doximity during the fourth quarter valued at $908,000. Quantinno Capital Management LP bought a new stake in shares of Doximity during the fourth quarter valued at about $246,000. Finally, Polar Capital Holdings Plc raised its stake in shares of Doximity by 218.9% during the fourth quarter. Polar Capital Holdings Plc now owns 382,695 shares of the company's stock valued at $20,432,000 after purchasing an additional 262,695 shares in the last quarter. Institutional investors and hedge funds own 87.19% of the company's stock.

Insider Activity

In other Doximity news, Director Regina M. Benjamin sold 10,000 shares of the business's stock in a transaction on Wednesday, June 25th. The shares were sold at an average price of $60.00, for a total transaction of $600,000.00. Following the completion of the transaction, the director owned 16,618 shares of the company's stock, valued at $997,080. The trade was a 37.57% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Timothy S. Cabral sold 10,000 shares of the business's stock in a transaction dated Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total value of $600,000.00. Following the transaction, the director directly owned 6,360 shares of the company's stock, valued at $381,600. This represents a 61.12% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 32,000 shares of company stock valued at $1,929,380 over the last 90 days. 31.30% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

DOCS has been the topic of a number of recent analyst reports. Evercore ISI upgraded shares of Doximity from an "in-line" rating to an "outperform" rating and lifted their price objective for the company from $50.00 to $70.00 in a research note on Wednesday, July 9th. Bank of America boosted their price target on shares of Doximity from $55.00 to $62.00 and gave the stock a "neutral" rating in a research report on Wednesday, June 25th. Zacks Research cut shares of Doximity from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, August 20th. Robert W. Baird boosted their price objective on Doximity from $75.00 to $80.00 and gave the stock an "outperform" rating in a report on Thursday. Finally, Truist Financial boosted their price objective on Doximity from $52.00 to $61.00 and gave the stock a "hold" rating in a report on Thursday, July 17th. Two research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and eleven have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $67.00.

Doximity Stock Up 2.1%

Shares of DOCS traded up $1.46 during trading hours on Monday, reaching $72.49. The company's stock had a trading volume of 1,680,530 shares, compared to its average volume of 2,220,993. The firm has a market cap of $13.58 billion, a price-to-earnings ratio of 72.49, a P/E/G ratio of 4.10 and a beta of 1.37. The company has a 50 day moving average of $63.60 and a two-hundred day moving average of $59.77. Doximity, Inc. has a 1-year low of $39.27 and a 1-year high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.36 EPS for the quarter, beating the consensus estimate of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.The company's revenue for the quarter was up 15.2% on a year-over-year basis. During the same period in the previous year, the business posted $0.28 earnings per share. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, analysts forecast that Doximity, Inc. will post 0.99 EPS for the current fiscal year.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.